Search

Global GIST Market Shows Steady Expansion Driven by Targeted Oncology Therapies Global gastrointestinal stromal tumor (GIST) market is demonstrating sustained growth as advances in molecular oncology and targeted therapies continue to redefine treatment standards. Valued at USD 1.08 billion in 2024, the market is projected to grow from USD 1.15 billion in 2025 to USD 1.76 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. This upward trajectory reflects increasing diagnostic accuracy, wider access to tyrosine kinase inhibitors, and a growing emphasis on personalized cancer care worldwide. Access the complete report https://www.24lifesciences.com/gastrointestinal-stromal-tumor-market-9149

Ultrasound Endoscope Market Size to Reach USD 3.6 Billion by 2032 | Growth Trends & Insights Global ultrasound endoscope market is witnessing steady and technology-driven growth as healthcare systems increasingly prioritize minimally invasive diagnostics and precision-guided interventions. Valued at USD 2.3 billion in 2024, the market is projected to reach USD 3.6 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. This upward trajectory reflects rising procedural volumes, expanding clinical applications, and continuous innovation in endoscopic imaging technologies across both developed and emerging healthcare markets. Ultrasound endoscopes have become indispensable tools in modern medicine, enabling clinicians to combine endoscopic visualization with high-resolution ultrasound imaging to improve diagnostic accuracy and therapeutic outcomes. Access the market report https://www.24lifesciences.com/ultrasound-endoscope-market-9926

Migraine With Brainstem Aura Drugs Market to Reach USD 1.51 Billion by 2031 | Growth Insights Global Migraine With Brainstem Aura drugs market is entering a phase of sustained expansion as healthcare systems place greater emphasis on rare and complex neurological disorders. Valued at USD 0.82 billion in 2024, the market is projected to grow from USD 0.88 billion in 2025 to USD 1.51 billion by 2031, registering a compound annual growth rate (CAGR) of 7.8% over the forecast period. Rising diagnostic accuracy, expanding access to specialty care, and innovation in targeted migraine therapies are reshaping treatment paradigms worldwide. Access the market report https://www.24lifesciences.com/migraine-with-brainstem-aura-drugs-market-9082

Porokeratosis Treatment Market Size to Reach USD 593.8 Million by 2031 | Growth Outlook & Insights Global porokeratosis treatment market is demonstrating steady and clinically driven growth as awareness of rare dermatological disorders increases and therapeutic strategies continue to advance. Valued at approximately USD 430.5 million in 2024, the market is projected to reach USD 593.8 million by 2031, expanding at a CAGR of 4.7% during the forecast period. This progression reflects growing diagnostic accuracy, wider access to specialist dermatology care, and sustained innovation in topical, procedural, and systemic treatment approaches. Access the market report https://www.24lifesciences.com/porokeratosis-treatment-market-9046

Piriformis Syndrome Market Size to Reach USD 2.1 Billion by 2031 | Growth Insights & Forecast Global piriformis syndrome market is entering a phase of sustained clinical and commercial expansion, driven by rising musculoskeletal disorder prevalence, improved diagnostic accuracy, and expanding access to multimodal pain management solutions. Valued at approximately USD 1.5 billion in 2024, the market is projected to reach USD 2.1 billion by 2031, growing at a CAGR of 5.2% during the forecast period. This growth reflects increasing awareness among clinicians and patients, alongside evolving therapeutic strategies that prioritize precision care and functional rehabilitation. Access the market report https://www.24lifesciences.com/piriformis-syndrome-market-9030